Member Info for violindog

Excellent news, another product in trial.

Matt, and that issue has always haunted SCLP untill the arrival of Vulps and Resmile. Im convinced Redmile will be giving guidance both to protect their investment and enhance the value. The only risk now is proving the science via trials and selling ones shares too early.

I agree with you Chester ! Not long until the year end to make the self imposed deadline. We may have ethics approval...fingers crossed... and tomorrow we may wake up to first pt dosed RNS.
To miss another trial time line would be very disappointing . So near and yet so far !!
Meanwhile...down in South Africa Covidity is hopefully working its wonder so all is not doom and gloom.

That run of 7 sell trades at 12:28 sure backs up the theory the SP is being "controlled " ? Hmm...

Will we get first patient dosed by AGM? Let's hope so. Good week ahead I feel!

So we should be expecting trial start very very soon. LD has stated Modi1 trial in 2021 . To meet SCLPs own target we only have this week and another 7 before our "make or break" 2022.

There was some talk of the ethics committee reviewing Moditope in late October. I hope we get the "first patient dosed" RNS soon...

Micky, AGM details are on their Web page.

Ruck, I think C7 echoes many thoughts. We are a perfect fit for BioNTec for example and I doubt their shareholders would mind following their founder....he's made them a fortune and even at a healthy premium SCLP are small change to many pharmaceutical companies. ?? Protect some assets in Zachary and live on in some form.
SCLP is now basically a Covid stock and an Immunotherapy stock, if Covidity is successful a split is a perfect option to protect value for existing shareholders.

Second doses of Covidity being administered by now.....one can only assume all is well.
Dummy buys above £2500 not being filled. Hopefully some more blue today.

Hasiba, afternoon. Yes not a good day today and I note your two support prices. We could however get news re CEPI funding ...but we WILL get news of Modi1 trial recruiting...shortly...as per LD in the results. We also have the second Covidity dose being administered this week so one can assume no current safety issues. This is all good news and I think (hope) the Modi trial starting will hopefully draw a line at at least 19 pence. Have to admit I'm very disappointed at the current price and can only read positive points in the latest RNS so why we trade at 19 p is beyond my comprehension.
Comfort is Redmile and Vulps support.
Good luck to you if you're trading SCLP, I wish I had the "gift" but I'm more of a Warren Buffett / Redmile /Vulps investor. I just need to switch off and ignore the swings ...short term capital errosion isn't fun to watch but with luck i will be rewarded . Best wishes to all.

Hi everyone, I hope we get the Modi1 RNS soon. Scib aside ...how great to have 2 trials bringing in data and leading to a massive revaluation.
Second Covidity dose due this week.

A very positive RNS today in my opinion so I wonder what caused the drop in SP yesterday. Hopefully we see a stout recovery today.

Redmile's CLN s due and LD 's 9 million share options will expire....is the date a coincidence I wonder ?

It's quite clear now why the CLN s were extended....data...data...data...by 2025 and hopefully some inked deals !

Can't see ANY negatives in the RNS , progressive outlook.

WTP, I really don't understand SCLPs thinking, why it wasn't announced with the results is beyond me... its almost as if they are driving the SP down intentionally.

Well, down 4% + on what I considered an excellent RNS.... wonder why this couldn't have waited and been released with the results tomorrow. So disappointing we are not making any progress with the share price considering all the positive progress on many fronts.

At this moment in time... EXACTLY the same quote to buy/sell for identical number of shares. Very odd.

Ruck, I will be up bright and early on the 3rd of Nov ...typing the RNS for 07:00 hrs....I may.. just may ...throw in Modi1 first pt recruited.